LOS ANGELES--(BUSINESS WIRE)--Banyan Corporation’s (OTCBB:BANY) subsidiary, Virtual Medical Systems, Inc. (“VMS”), announces it has now sold 66 of its new VT3000 Nerve Conduction Velocity (NCV) testing devices since November 2006. The VT3000 is a state of the art NCV device offering live viewing and supervision of testing by board certified physicians. These 66 machines are expected to add $1.58 million in revenue to VMS. The company, in an earlier release, reported that management projected 2007 sales of 144 machines corresponding to $3.4 million in revenue. Now, as a result of these increased sales, management has revised its estimates upward to 166 machines and $3.98 million in revenue.